Tyra Biosciences, Inc. Share Price

Tyra Biosciences, Inc. Share Price

NASDAQ: TYRA | Small Cap
$21.05
-$0.45 (-2.09%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Tyra Biosciences, Inc. Stock Performance

Open
$20.96
Prev. Close
$21.50
Circuit Range
N/A
Day Range
$20.36 - $21.12
Year Range
$13.88 - $40.42
Volume
44,649
Average Traded
$20.80

Tyra Biosciences, Inc. Share Price Today

As of 31 October 2026, Tyra Biosciences, Inc.'s share price is $21.05. The stock opened at $20.96, compared to its previous close of $21.50. During today's trading session, Tyra Biosciences, Inc.'s share price traded between $20.36 and $21.12, with an average price of $20.74. Over the past 52 weeks, the stock has recorded a high of $40.42 and a low of $13.88. In terms of performance, Tyra Biosciences, Inc.'s share price has declined by 39.36% over the last six months and is up 33.06% on a year-on-year basis.

Tyra Biosciences, Inc. Share Price Chart

Line chart of the Tyra Biosciences, Inc. price trend over the selected period. The price fell overall, ranging from 20.36 to 21.63, ending at 21.05.
$20.36$21.12
L
Show Current Price
H

Tyra Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.25B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.16
Revenue (TTM)
$0.00
Return On Equity (TTM)
-41.91%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-52.58%

Tyra Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$29.86-$33.51-$39.31-$45.56
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-12.22%-17.31%-15.90%

Tyra Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$55.33-$69.13-$86.48-$119.95
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-24.94%-25.10%-38.70%

About Tyra Biosciences, Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Tyra Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$22.10
$21.08
-3.70%
Sep 2026
$25.11
$21.89
-16.15%
Aug 2026
$30.84
$26.11
-18.22%
Jul 2026
$32.09
$31.92
-0.09%
Jun 2026
$32.50
$31.95
-4.43%
May 2026
$35.38
$33.43
-3.70%
Apr 2026
$39.45
$34.72
-9.38%
Mar 2026
$32.65
$38.31
+14.91%
Feb 2026
$30.68
$33.34
+7.88%
Jan 2026
$26.20
$30.91
+17.78%
Dec 2025
$21.82
$26.24
+16.34%
Nov 2025
$15.58
$22.55
+42.57%

TYRA Share Price FAQs